Healthcare 01 (Jul 08 - Apr 15)

[winston]

5 Biotech ETFs to Buy for Evolving Growth

Biotechnology will likely continue to dominate with innovation for years to come

By David Fabian

http://investorplace.com/2015/03/biotec ... QyozdKUd1Y

[winston]

Are Large-Cap Biotech Stocks in a Bubble?

The sector has put up big returns, but the valuations of the four largest stocks remain low

By Daniel Putnam

Source: InvestorPlace

http://investorplace.com/2015/03/large- ... Qyow9KUd1Y

[winston]

Are Large-Cap Biotech Stocks in a Bubble?

The sector has put up big returns, but the valuations of the four largest stocks remain low

By Daniel Putnam

Source: InvestorPlace

http://investorplace.com/2015/03/large- ... Qyow9KUd1Y

[winston]

How We Turned $100,000 Into $788,000 in Under Four Years By Dr. Steve Sjuggerud

"If you catch just one biotech bull market in your lifetime, you may never have to work again…"

I've written that many times here in DailyWealth.

I hope you've taken me up on that advice – and caught this bull market – because it has been a great one.

Subscribers to my True Wealth Systems letter sure have taken advantage of this bull market…

TWS subscribers who followed my advice since the beginning of 2012 would have turned $100,000 into more than $788,000. We didn't do something complicated, either…

We bought a simple biotech index fund – an exchange-traded fund (ETF). Here are our trades:

Start End Gain $ 100,000
1/4/2012 11/5/2012 56% $ 156,000
12/5/2012 4/2/2014 184% $ 443,040
10/1/2014 Today 78% $ 788,611
We did two things right…

We bought a "double-long" ETF, which magnified our gains.

We've stuck with it. We haven't bailed, even though readers are up nearly 700%.

You know what? We're STILL not selling yet.

This biotech bull market – in our opinion – is not over yet.

We get it… We know that a 700% gain in a little more than three years is big. We can ask, just like you, how much more is left?

When we ask ourselves objectively, we still think there's more upside potential.

Here are two reasons why:

1. Biotech stocks are expensive… but they still aren't near the nose-bleed levels they reached in their last great bull market. Take a look:


Don't get me wrong… I realize today's values in biotech stocks are not sustainable. I realize today's near-bubble in biotech stocks will burst, someday. But right now, I don't want to miss out on the fun before the day of reckoning finally arrives.

2. The general public hasn't gone crazy over biotech stocks yet. (For example, according to Jason Goepfert of SentimenTrader.com, we are not seeing an extreme in investor optimism in biotech stocks yet.)

At the peak of a market, the general public is usually crazy about a sector. But the general public hasn't been enamored with biotech – yet. When the general public is finally excited about biotech, the top will be near. We are not there yet.

We will get out of our biotech trade when our True Wealth Systems computers tell us it's time to get out of biotech… At that point, we'll be done. We'll be satisfied. We'll have done our job for our subscribers, pocketing hundreds of percent in a couple years in an ETF.

But we are not there yet…

It's definitely late in the game in the biotech bull market… But we think there's a bit more juice to squeeze out of it.

It ain't over yet.

Source: Daily Wealth

[winston]

One of the world’s most popular sectors could be reversing now by Chris Kimble

CLICK ON CHART TO ENLARGE

IBB [the iShares Nasdaq Biotechnology Fund] could be creating the largest reversal pattern (bearish wick) in its history, on a monthly basis…

This potential reversal pattern is unfolding at a steep rising resistance line… and at a long-term Fibonacci extension level.

As you can see, monthly momentum is also at a level not seen in the history of IBB.

If you would like to see some other “Eiffel Tower” patterns in the past and how they played out, click here.

Since this is a monthly pattern, it could take a while to see if this is the mother of all bearish wicks or not.

Remember, few sectors on the planet are hotter than biotech right now. What takes place here could send a message to quite a few indices, sectors, and stocks!

Source: Kimble Charting Solutions

http://thecrux.com/this-chart-says-one- ... rsing-now/

[winston]

The boom in health care marches on… Walgreens (pharmacies), Express Scripts (pharmacy benefit manager), and Mylan (biotech) hit all-time highs.

[winston]

Biotech stocks continue their surge… sector fund IBB is up 34% in six months.

[winston]

Big Pharma giants Pfizer and Bristol-Myers Squibb rise more than 25% in six months.

[winston]

Health care giants Abbott Laboratories and St. Jude Medical hit all-time highs.

[winston]

Biotech continues to beat the market… sector fund IBB is up more than 20% in 2015.